Simon; Barry J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Simon; Barry J..The latest application filed is for "tumoricidal and antimicrobial compositions and methods".

Company Profile

6.13.17

Simon; Barry J. - Culver City CA
Simon; Barry J. - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Nant cancer vaccine Grant 11,439,697 - Soon-Shiong , et al. September 13, 2	2022-09-13
Tumoricidal And Antimicrobial Compositions And Methods App 20220175838 - Klingemann; Hans G. ; et al.	2022-06-09
Tumoricidal And Antimicrobial Compositions And Methods App 20220160768 - Klingemann; Hans G. ; et al.	2022-05-26
Tumoricidal and antimicrobial compositions and methods Grant 11,304,977 - Klingemann , et al. April 19, 2	2022-04-19
Genetically Modified Nk-92 Cells Having A Safety Switch App 20220062343 - Lee; Tien ; et al.	2022-03-03
Hypoxic NK cells and methods therefor Grant 11,221,328 - Soon-Shiong , et al. January 11, 2	2022-01-11
Tumoricidal and antimicrobial compositions and methods Grant 11,213,547 - Klingemann , et al. January 4, 2	2022-01-04
Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer Grant 11,207,350 - Lee , et al. December 28, 2	2021-12-28
Coordinated multi-prong cancer therapy Grant 11,207,392 - Soon-Shiong , et al. December 28, 2	2021-12-28
Nant Cancer Vaccine App 20210353730 - Soon-Shiong; Patrick ; et al.	2021-11-18
Genetically Modified Nk-92 Cells And Monoclonal Antibodies For The Treatment Of Cancer App 20210236550 - Lee; Tien ; et al.	2021-08-05
Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer Grant 11,000,550 - Lee , et al. May 11, 2	2021-05-11
Genetically Modified Nk-92 Cells And Monoclonal Antiboides For The Treatment Of Cancer App 20200306312 - Lee; Tien ; et al.	2020-10-01
Tumoricidal and antimicrobial composition Grant 10,772,912 - Klingemann , et al. Sept	2020-09-15
Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer Grant 10,736,921 - Lee , et al. A	2020-08-11
Tumoricidal and antimicrobial compositions and methods Grant 10,646,516 - Klingemann , et al.	2020-05-12
Tumoricidal And Antimicrobial Compositions And Methods App 20200038445 - Klingemann; Hans G. ; et al.	2020-02-06
Tumoricidal and antimicrobial compositions and methods Grant 10,517,895 - Klingemann , et al. Dec	2019-12-31
Genetically Modified Nk-92 Cells And Monoclonal Antiboides For The Treatment Of Cancer App 20190365816 - Lee; Tien ; et al.	2019-12-05
Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer Grant 10,456,420 - Lee , et al. Oc	2019-10-29
Tumoricidal And Antimicrobial Compositions And Methods App 20190192570 - Klingemann; Hans G. ; et al.	2019-06-27
Tumoricidal And Antimicrobial Compositions And Methods App 20190192569 - Klingemann; Hans G. ; et al.	2019-06-27
Tumoricidal And Antimicrobial Compositions And Methods App 20190192568 - Klingemann; Hans G. ; et al.	2019-06-27
Tumoricidal And Antimicrobial Compositions And Methods App 20190125801 - Klingemann; Hans G. ; et al.	2019-05-02
Tumoricidal and antimicrobial compositions and methods Grant 10,258,649 - Klingemann , et al.	2019-04-16
Genetically Modified Nk-92 Cells And Monoclonal Antibodies For The Treatment Of Cancer App 20180193383 - Lee; Tien ; et al.	2018-07-12
Nk-92 Cells In Combination Therapy With Cancer Drugs App 20170304364 - Lee; Tien ; et al.	2017-10-26
Tumoricidal And Antimicrobial Compositions And Methods App 20160250256 - Klingemann; Hans G. ; et al.	2016-09-01
Protocol And Media For Storage And Transport Of Nk-92 Cell Line App 20160244716 - Klingemann; Hans G. ; et al.	2016-08-25

Company Registrations

SEC

0001647994

Simon Barry J.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.